Skip to content

    NovoCure (NVCR) financials

    View NVCR earnings calls

    Price

    Market Cap

    Sector

    Rank

    Performance+24.0% 1Y

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $150.36M
    $155.09M
    $161.27M
    $154.99M
    $158.81M
    +5.6%
    $167.20M
    +7.8%
    $174.06M
    +7.9%
    $183.58M
    +18.4%
    Strengthening
    Operating Profit
    -$33.58M
    -$32.09M
    -$63.30M
    -$37.87M
    -$39.52M
    -17.7%
    -$36.02M
    -12.2%
    -$67.42M
    -6.5%
    -$10.56M
    +72.1%
    Strengthening
    Net Profit
    -$33.38M
    -$30.57M
    -$65.92M
    -$34.32M
    -$40.14M
    -20.3%
    -$37.27M
    -21.9%
    -$71.14M
    -7.9%
    -$15.66M
    +54.4%
    Strengthening
    EPS
    $-0.31
    $-0.28
    $-0.31
    $-0.36
    -16.1%
    $-0.33
    -17.9%
    $-0.62
    $-0.13
    +58.1%
    Strengthening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    -$22.73M
    -$21.59M
    -$55.21M
    -$30.30M
    -$34.98M
    -53.9%
    -$30.02M
    -39.1%
    -$69.26M
    -25.5%
    -$12.45M
    +58.9%
    Stable
    MarginsOPM
    -22.3%
    -20.7%
    -39.3%
    -24.4%
    -24.9%
    -11.5%
    -21.5%
    -4.1%
    -38.7%
    +1.3%
    -5.8%
    +76.5%
    Strengthening
    Tax
    -46.8%
    -41.6%
    -19.4%
    -13.3%
    -14.8%
    +68.5%
    -24.1%
    +42.0%
    -2.7%
    +86.0%
    -25.8%
    -93.9%
    Strengthening
    ReturnsROIC
    2.4%
    2.2%
    4.8%
    2.5%
    2.9%
    +20.3%
    2.7%
    +21.9%
    5.2%
    +7.9%
    1.1%
    -54.4%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$140.62M$177.32M$234.67M$208.80M$115.33M$240.82M$163.77M$93.55M$93.70M
    Short-Term Investments
    Total Current Assets$321.37M$439.95M$999.44M$1.07B$1.11B$1.03B$1.11B$646.73M$638.52M
    Net PP&E$8.44M$26.91M$30.40M$40.96M$56.27M$86.31M$104.78M$124.93M$119.16M
    Goodwill
    Intangibles
    Total Assets$339.79M$479.45M$1.05B$1.14B$1.19B$1.15B$1.24B$804.33M$795.19M
    LiabilitiesTotal Current Liabilities$64.56M$86.31M$113.61M$142.60M$158.78M$179.12M$756.39M$223.23M$220.71M
    Short-Term Debt
    Long-Term Debt$149.27M$149.42M$429.90M$562.22M$565.51M$568.82M$97.30M$195.05M
    Long-Term Leases$0$14.14M$14.29M$13.00M$18.76M$27.42M$19.97M$41.65M$37.53M
    Total Liabilities$227.53M$261.66M$575.46M$729.00M$750.48M$783.63M$880.61M$463.86M$457.10M
    EquityCommon Stock & APIC$0$0$0$0$0$0$0$0$0
    Retained Earnings-$643.65M-$650.88M-$631.08M-$685.93M-$778.46M-$985.50M-$1.15B-$1.29B-$1.38B
    Total Equity$112.26M$217.79M$476.53M$410.49M$441.17M$362.50M$360.18M$340.47M$338.09M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$1.86M$26.62M$99.15M$82.76M$30.79M-$73.34M-$26.37M-$49.03M-$2.81M
    Cash from Investing-$5.49M-$51.67M-$472.85M-$144.83M-$139.96M$184.15M-$140.24M$437.28M$409.13M
    Cash from Financing$69.37M$61.68M$440.21M$25.70M$15.49M$15.79M$90.31M-$451.34M-$454.60M
    SummaryCapital Expenditure-$6.71M-$10.48M-$14.97M-$24.17M-$21.36M-$27.09M-$42.85M-$26.65M-$22.62M
    Free Cash Flow-$8.58M$16.14M$84.18M$58.59M$9.43M-$100.43M-$69.22M-$75.68M-$25.43M
    FCF Margin-3.5%4.6%17.0%11.0%1.8%-19.7%-11.4%

    Ratios